|
1
|
Odabas S, Elçin AE and Elçin YM: Isolation
and characterization of mesenchymal stem cells. Methods Mol Biol.
1109:47–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Valenti MT, Garbin U, Pasini A, Zanatta M,
Stranieri C, Manfro S, Zucal C and Dalle Carbonare L: Role of
ox-PAPCs in the differentiation of mesenchymal stem cells (MSCs)
and Runx2 and PPARγ2 expression in MSCs-like of osteoporotic
patients. PLoS One. 6:e203632011. View Article : Google Scholar
|
|
3
|
Cheng SL, Shao JS, Charlton-Kachigian N,
Loewy AP and Towler DA: MSX2 promotes osteogenesis and suppresses
adipogenic differentiation of multipotent mesenchymal progenitors.
J Biol Chem. 278:45969–45977. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lim LH and Pervaiz S: Annexin 1: The new
face of an old molecule. FASEB J. 21:968–975. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
De BK, Misono KS, Lukas TJ, Mroczkowski B
and Cohen S: A calcium-dependent 35-kilodalton substrate for
epidermal growth factor receptor/kinase isolated from normal
tissue. J Biol Chem. 261:13784–13792. 1986.PubMed/NCBI
|
|
6
|
Bai XF, Ni XG, Zhao P, Liu SM, Wang HX,
Guo B, Zhou LP, Liu F, Zhang JS, Wang K, et al: Overexpression of
annexin 1 in pancreatic cancer and its clinical significance. World
J Gastroenterol. 10:1466–1470. 2004.PubMed/NCBI
|
|
7
|
Masaki T, Tokuda M, Ohnishi M, Watanabe S,
Fujimura T, Miyamoto K, Itano T, Matsui H, Arima K, Shirai M, et
al: Enhanced expression of the protein kinase substrate annexin in
human hepatocellular carcinoma. Hepatology. 24:72–81.
1996.PubMed/NCBI
|
|
8
|
Lecona E, Barrasa JI, Olmo N, Llorente B,
Turnay J and Lizarbe MA: Upregulation of Annexin A1 expression by
butyrate in human colon adenocarcinoma cells: Role of p53, NF-Y,
and p38 mitogen-activated protein kinase. Mol Cell Biol.
28:4665–4674. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Petrella A, Festa M, Ercolino SF, Zerilli
M, Stassi G, Solito E and Parente L: Annexin-1 downregulation in
thyroid cancer correlates to the degree of tumor differentiation.
Cancer Biol Ther. 5:643–647. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen D, Nooraie F, Elshimali Y, Lonsberry
V, He J, Bose S, Chia D, Seligson D, Chang HR and Goodglick L:
Decreased expression of Annexin A1 is correlated with breast cancer
development and progression as determined by a tissue microarray
analysis. Hum Pathol. 37:1583–1591. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garcia Pedrero JM, Fernandez MP, Morgan
RO, Herrero Zapatero A, Gonzalez MV, Suarez Nieto C and Rodrigo JP:
Annexin A1 down-regulation in head and neck cancer is associated
with epithelial differentiation status. Am J Pathol. 164:73–79.
2004. View Article : Google Scholar
|
|
12
|
Rodrigo JP, García-Pedrero JM, González
MV, Fernández MP, Suárez C and Herrero A: Expression of Annexin A1
in normal and chronically inflamed nasal mucosa. Arch Otolaryngol
Head Neck Surg. 130:211–215. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bizzarro V, Fontanella B, Franceschelli S,
Pirozzi M, Christian H, Parente L and Petrella A: Role of Annexin
A1 in mouse myoblast cell differentiation. J Cell Physiol.
224:757–765. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Damazo AS, Moradi-Bidhendi N, Oliani SM
and Flower RJ: Role of annexin 1 gene expression in mouse
craniofacial bone development. Birth Defects Res A Clin Mol
Teratol. 79:524–532. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salasznyk RM, Klees RF, Hughlock MK and
Plopper GE: ERK signaling pathways regulate the osteogenic
differentiation of human mesenchymal stem cells on collagen I and
vitronectin. Cell Commun Adhes. 11:137–153. 2004. View Article : Google Scholar
|
|
16
|
Alldridge LC, Harris HJ, Plevin R, Hannon
R and Bryant CE: The annexin protein lipocortin 1 regulates the
MAPK/ERK pathway. J Biol Chem. 274:37620–37628. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huo XF and Zhang JW: Annexin1 regulates
the erythroid differentiation through ERK signaling pathway.
Biochem Biophys Res Commun. 331:1346–1352. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kassis I, Zangi L, Rivkin R, Levdansky L,
Samuel S, Marx G and Gorodetsky R: Isolation of mesenchymal stem
cells from G-CSF-mobilized human peripheral blood using fibrin
microbeads. Bone Marrow Transplant. 37:967–976. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi YJ, Lee JY, Lee SJ, Chung C-P and
Park YJ: Alpha-adrenergic blocker mediated osteoblastic stem cell
differentiation. Biochem Biophys Res Commun. 416:232–238. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alldridge LC and Bryant CE: Annexin 1
regulates cell proliferation by disruption of cell morphology and
inhibition of cyclin D1 expression through sustained activation of
the ERK1/2 MAPK signal. Exp Cell Res. 290:93–107. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Croxtall JD, Gilroy DW, Solito E,
Choudhury Q, Ward BJ, Buckingham JC and Flower RJ: Attenuation of
glucocorticoid functions in an Anx-A1−/− cell line.
Biochem J. 371:927–935. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mei Y, Bian C, Li J, Du Z, Zhou H, Yang Z
and Zhao RC: miR-21 modulates the ERK-MAPK signaling pathway by
regulating SPRY2 expression during human mesenchymal stem cell
differentiation. J Cell Biochem. 114:1374–1384. 2013. View Article : Google Scholar
|
|
23
|
Mu D, Gao Z, Guo H, Zhou G and Sun B:
Sodium butyrate induces growth inhibition and apoptosis in human
prostate cancer DU145 cells by up-regulation of the expression of
Annexin A1. PLoS One. 8:e749222013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gavins FN and Hickey MJ: Annexin A1 and
the regulation of innate and adaptive immunity. Front Immunol.
3:3542012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gerke V and Moss SE: Annexins: From
structure to function. Physiol Rev. 82:331–371. 2002.PubMed/NCBI
|
|
26
|
Zeng W, Yan Y, Zhang F, Zhang C and Liang
W: Chrysin promotes osteogenic differentiation via ERK/MAPK
activation. Protein Cell. 4:539–547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yi C, Liu D, Fong CC, Zhang J and Yang M:
Gold nanoparticles promote osteogenic differentiation of
mesenchymal stem cells through p38 MAPK pathway. ACS Nano.
4:6439–6448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim SH, Choi YR, Park MS, Shin JW, Park
KD, Kim SJ and Lee JW: ERK 1/2 activation in enhanced osteogenesis
of human mesenchymal stem cells in poly(lactic-glycolic acid) by
cyclic hydrostatic pressure. J Biomed Mater Res A. 80:826–836.
2007. View Article : Google Scholar
|
|
29
|
Castro-Caldas M, Mendes AF, Duarte CB and
Lopes MC: Dexamethasone-induced and estradiol-induced CREB
activation and annexin 1 expression in CCRF-CEM lymphoblastic
cells: Evidence for the involvement of cAMP and p38 MAPK. Mediators
Inflamm. 12:329–337. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jaiswal RK, Jaiswal N, Bruder SP,
Mbalaviele G, Marshak DR and Pittenger MF: Adult human mesenchymal
stem cell differentiation to the osteogenic or adipogenic lineage
is regulated by mitogen-activated protein kinase. J Biol Chem.
275:9645–9652. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Almawi WY, Saouda MS, Stevens AC, Lipman
ML, Barth CM and Strom TB: Partial mediation of glucocorticoid
antiproliferative effects by lipocortins. J Immunol. 157:5231–5239.
1996.PubMed/NCBI
|
|
32
|
Schlaepfer DD and Haigler HT: Expression
of annexins as a function of cellular growth state. J Cell Biol.
111:229–238. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheng SL, Yang JW, Rifas L, Zhang SF and
Avioli LV: Differentiation of human bone marrow osteogenic stromal
cells in vitro: Induction of the osteoblast phenotype by
dexamethasone. Endocrinology. 134:277–286. 1994.PubMed/NCBI
|
